Mode Diagnostics
Glasgow
About Mode Diagnostics
Mode Diagnostics is exploiting the electrochemical properties of biomarkers to produce novel assays for home diagnostic purposes. The company has developed a suite of technologies comprising assay development techniques, biosensing capabilities, microfabrication, electronics and wireless communications. MODE is an innovative product development company rapidly building a pipeline of user friendly and medically informative health screening products specifically designed for the Physicians office and consumer self-testing. MODE’s proprietary platform – measure – is a flexible, low-cost and hygenic platform that can easily be configured to create health tests for both the Physicians Office and Consumer self-testing. MODE’s first product, measure BOWEL HEALTH represents an evolution in bowel cancer screening (faceal occult blood) offering significant improvements over the current testing methods.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.7M
- Funding stage: M&A
- Last round: Series C (Jan 2014)
- Website: modehealth.com
- Phone: +44 (0) 141 330 8675
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/mode-diagnostics-1597863 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.